Cargando…
Estimation of YKL-40 Acute-Phase Protein in Serum of Patients with Periodontal Disease and Healthy Individuals: A Clinical-Biochemical Study
OBJECTIVE: YKL-40, an acute-phase protein, is a novel potential inflammatory marker. It is a member of “mammalian chitinase-like proteins.” YKL-40 is secreted by activated neutrophils and macrophages in both acute and chronic inflammation. It is also shown to be produced by vascular smooth muscle an...
Autores principales: | Chavan, Vinay, Sabavath, Srinu, Babu, C. Hemachandra, Boyapati, Laxman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7145237/ https://www.ncbi.nlm.nih.gov/pubmed/32308286 http://dx.doi.org/10.4103/ccd.ccd_471_18 |
Ejemplares similares
-
Serum YKL-40 and colorectal cancer
por: Cintin, C, et al.
Publicado: (1999) -
Serum YKL-40 Levels in Patients with Gastric Cancer
por: Itik, Veyis, et al.
Publicado: (2011) -
Estimation and comparison of serum cortisol levels in periodontally diseased patients and periodontally healthy individuals: A clinical-biochemical study
por: Rohini, G., et al.
Publicado: (2015) -
Unveiling YKL-40, from Serum Marker to Target Therapy in Glioblastoma
por: Iwamoto, Fabio M., et al.
Publicado: (2014) -
Serum YKL-40 levels and disease characteristics in patients with rheumatoid arthritis
por: Jafari-Nakhjavani, Mohammad Reza, et al.
Publicado: (2019)